Daré Bioscience, Inc.
DARE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,054 | -$30,161 | -$30,948 | -$38,696 |
| Dep. & Amort. | $42 | $38 | $24 | $26 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,203 | $2,531 | $2,159 | $1,600 |
| Change in WC | $5,814 | -$10,427 | $10,700 | $8,728 |
| Other Non-Cash | $1,389 | -$837 | -$23 | -$422 |
| Operating Cash Flow | $5,394 | -$38,857 | -$18,088 | -$28,764 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$573 | -$629 | -$63 | -$15 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$573 | -$629 | -$63 | -$15 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$18 | $267 | $0 | $0 |
| Stock Issued | $454 | $9,347 | $1,219 | $75,314 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $6,023 | $125 | $533 |
| Financing Cash Flow | $434 | $15,637 | $1,343 | $75,847 |
| Forex Effect | -$68 | -$10 | -$196 | -$64 |
| Net Chg. in Cash | $5,187 | -$23,859 | -$17,004 | $47,005 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,811 | $34,670 | $51,674 | $4,669 |
| End Cash | $15,998 | $10,811 | $34,670 | $51,674 |
| Free Cash Flow | $4,821 | -$39,486 | -$18,151 | -$28,779 |